Biogen Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIIB Nasdaq 2834 www.biogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biogen Inc.

Biogen expected to slightly beat third-quarter earnings as lupus trial data loom, Jefferies says - Oct 6th, 2026 11:06 am
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report? - Oct 6th, 2026 9:10 am
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus - Oct 2nd, 2026 9:20 am
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise? - Oct 2nd, 2026 7:00 am
1 Profitable Stock Worth Investigating and 2 We Ignore - Oct 1st, 2026 5:41 am
HLS Therapeutics Announces Board of Directors Changes - Oct 1st, 2026 5:00 am
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - Sep 28th, 2026 10:23 pm
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs? - Sep 28th, 2026 7:41 am
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack - Sep 25th, 2026 4:56 pm
How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data - Sep 23rd, 2026 8:17 am
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets - Sep 23rd, 2026 6:41 am
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva - Sep 23rd, 2026 5:03 am
Biogen (BIIB) Posts New Kidney Trial Data, Is It Still 5% Undervalued? - Sep 23rd, 2026 3:15 am
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day - Sep 21st, 2026 10:40 am
Novo Nordisk shares plunge over 7% as new targets fail to reassure investors - Sep 21st, 2026 9:55 am
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN - Sep 17th, 2026 2:15 pm
How AbbVie's Neuroscience Portfolio Has Transformed Over the Years - Sep 16th, 2026 9:31 am
Is Biogen Stock Outperforming the S&P 500? - Sep 16th, 2026 4:36 am
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease - Sep 16th, 2026 12:00 am
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside? - Sep 15th, 2026 1:47 pm